(
A) Western blots comparing cellular levels of DprA (R3833) and DprA-GFP (R4262) produced from the
CEPlac platform in cells lacking native
dprA in varying concentrations of IPTG. α-DprA antibodies used. Samples at each IPTG concentration corrected by OD to render direct comparison of cellular levels possible. Cellular levels of DprA-GFP estimated from Western blots compared to purified DprA as previously described (
Johnston et al., 2018). (
B) Transformation efficiency of a
CEPlac-dprA-gfp,
dprA- strain (R4262) in an IPTG concentration gradient. R304 chromosomal DNA (50 ng mL
−1), conferring streptomycin resistance via
rpsL41 point mutation (
Salles et al., 1992), used to transform. Error bars represent triplicate repeats. (
C) Competence profiles of a R4262 strain possessing
CEPlac-dprA-gfp and
ssbB-luc in an IPTG concentration gradient. Appropriate IPTG concentration present from the beginning of the culture. Competence induced by addition of CSP at t = 0, when OD = ~0.05. Plots representative of triplicate repeats.